Filings

1 document · 1 match

1. ACXP Acurx Pharmaceuticals, Inc. 10-K 2026-03-12

   Item 9A. Controls and Procedures.

   material weaknesses in our internal control over financial reporting will not be identified in the future. Our failure to implement
   1 match in this document Show context Copy citation